Hyperkalemic periodic paralysis: genes and variants
Hyperkalemic periodic paralysis is linked to 2 analyzed proteins (SCN4A and CLCN1). 63 DNA variants are known to cause it; 765 more are uncertain, and 9 of those already look disease-causing on computable evidence.
Last updated 2026-09-30. Research information, not medical advice.
Genes linked to Hyperkalemic periodic paralysis
SCN4A: Sodium channel protein type 4 subunit alpha
Its rapid sodium current initiates and propagates skeletal-muscle action potentials. Gain- and loss-of-function variants cause disorders of muscle excitability including sodium-channel myotonia, paramyotonia congenita, periodic paralysis, and some congenital myopathies.
62 disease-causing and 765 uncertain variants in SCN4A are linked to Hyperkalemic periodic paralysis.
CLCN1: Chloride channel protein 1
Its chloride conductance stabilizes the resting membrane potential of skeletal muscle and prevents repetitive firing after contraction. Loss-of-function variants cause myotonia congenita, with delayed muscle relaxation and stiffness.
1 disease-causing and 0 uncertain variants in CLCN1 are linked to Hyperkalemic periodic paralysis.
Where Hyperkalemic periodic paralysis variants cluster
- SCN4A S4 of repeat II (positions 665–682): 7 of 62 disease-causing changes, 11.5× more than its size predicts.
- SCN4A Cytoplasmic (positions 1463–1481): 7 of 62 disease-causing changes, 10.9× more than its size predicts.
- SCN4A S4 of repeat IV (positions 1446–1462): 6 of 62 disease-causing changes, 10.4× more than its size predicts.
- SCN4A Cytoplasmic (positions 1143–1159): 5 of 62 disease-causing changes, 8.7× more than its size predicts.
- SCN4A S1 of repeat IV (positions 1355–1372): 4 of 62 disease-causing changes, 6.6× more than its size predicts.
Known disease-causing variants in Hyperkalemic periodic paralysis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SCN4A L250P | 250 | I | Disease-causing (★★) |
| SCN4A V445M | 445 | I | Disease-causing (★★) |
| SCN4A V445L | 445 | I | Disease-causing (★★) |
| SCN4A A1156S | 1156 | III | Disease-causing (★★) |
| SCN4A T1313M | 1313 | III | Disease-causing (★★) |
| SCN4A M1370V | 1370 | IV | Disease-causing (★★) |
| SCN4A M1476I | 1476 | IV | Disease-causing (★★) |
| SCN4A R672C | 672 | II | Disease-causing (★★) |
| SCN4A R672G | 672 | II | Disease-causing (★★) |
| SCN4A R672S | 672 | II | Disease-causing (★★) |
| SCN4A R675G | 675 | II | Disease-causing (★★) |
| SCN4A R675W | 675 | II | Disease-causing (★★) |
| SCN4A I693T | 693 | II | Disease-causing (★★) |
| SCN4A A1156T | 1156 | III | Disease-causing (★★) |
| SCN4A P1158S | 1158 | III | Disease-causing (★★) |
| SCN4A P1158L | 1158 | III | Disease-causing (★★) |
| SCN4A R1448P | 1448 | IV | Disease-causing (★★) |
| SCN4A R1463S | 1463 | IV | Disease-causing (★★) |
| SCN4A M1476T | 1476 | IV | Disease-causing (★★) |
| SCN4A M1476V | 1476 | IV | Disease-causing (★★) |
| SCN4A R222Q | 222 | I | Disease-causing (★★) |
| SCN4A S804F | 804 | II | Disease-causing (★★) |
| SCN4A M1360V | 1360 | IV | Disease-causing (★★) |
| SCN4A L1436P | 1436 | IV | Disease-causing (★★) |
| SCN4A R1454W | 1454 | IV | Disease-causing (★★) |
| SCN4A V1458F | 1458 | IV | Disease-causing (★★) |
| SCN4A I692M | 692 | II | Disease-causing (★★) |
| SCN4A R1135C | 1135 | III | Disease-causing (★★) |
| SCN4A R1142Q | 1142 | III | Disease-causing (★★) |
| SCN4A I1310N | 1310 | III | Disease-causing (★★) |
| SCN4A I1455T | 1455 | IV | Disease-causing (★★) |
| SCN4A L1461P | 1461 | IV | Disease-causing (★★) |
| SCN4A I1160V | 1160 | III | Disease-causing (★★) |
| SCN4A G1306V | 1306 | III | Disease-causing (★★) |
| SCN4A M1592I | 1592 | IV | Disease-causing (★★) |
| SCN4A Q1633E | 1633 | IV | Disease-causing (★★) |
| SCN4A E1702K | 1702 | Cytoplasmic | Disease-causing (★★) |
| SCN4A F1705I | 1705 | Cytoplasmic | Disease-causing (★★) |
| SCN4A A1152D | 1152 | III | Disease-causing (★★) |
| SCN4A R1463L | 1463 | IV | Disease-causing (★) |
| SCN4A I693S | 693 | II | Disease-causing (★) |
| SCN4A R1448G | 1448 | IV | Disease-causing (★) |
| SCN4A R669C | 669 | II | Disease-causing (★) |
| SCN4A T1313A | 1313 | III | Disease-causing (★) |
| SCN4A S1434P | 1434 | IV | Disease-causing (★) |
| SCN4A R1463H | 1463 | IV | Disease-causing (★) |
| SCN4A F671C | 671 | II | Disease-causing (★) |
| SCN4A M1370T | 1370 | IV | Disease-causing (★) |
| SCN4A L250R | 250 | I | Disease-causing (★) |
| SCN4A A444D | 444 | I | Disease-causing (★) |
| SCN4A M203K | 203 | I | Disease-causing (★) |
| SCN4A I588V | 588 | II | Disease-causing (★) |
| SCN4A T592I | 592 | II | Disease-causing (★) |
| SCN4A A715P | 715 | II | Disease-causing (★) |
| SCN4A N1366K | 1366 | IV | Disease-causing (★) |
| SCN4A A1481D | 1481 | IV | Disease-causing (★) |
| SCN4A I239V | 239 | I | Disease-causing (★) |
| SCN4A Q270K | 270 | I | Disease-causing (★) |
| SCN4A N440K | 440 | I | Disease-causing (★) |
| SCN4A V1293L | 1293 | III | Disease-causing (★) |
Showing 60 of 63.
Uncertain variants in Hyperkalemic periodic paralysis that look disease-causing
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SCN4A A715T | 715 | II | Conflicting reports (★) | +7: A715P at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.932 |
| SCN4A S1434Y | 1434 | IV | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; S1434P at the same position is pathogenic; seen in 7e-07 of gnomAD DNA copies; REVEL 0.897 |
| SCN4A R1454Q | 1454 | IV | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; R1454W at the same position is pathogenic; seen in 2.7e-06 of gnomAD DNA copies; REVEL 0.910 |
| SCN4A R1463C | 1463 | IV | Uncertain (★) | +7: 4 other pathogenic changes within 3 positions; R1463L at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.887 |
| SCN4A F1705L | 1705 | Cytoplasmic | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; F1705I at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.876 |
| SCN4A R1448L | 1448 | IV | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R1448P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.94 |
| SCN4A I1455S | 1455 | IV | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; I1455T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| SCN4A E1702V | 1702 | Cytoplasmic | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; E1702K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 |
| SCN4A M1493V | 1493 | IV | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; M1493I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.83 |
Which prediction tools work for Hyperkalemic periodic paralysis
How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 95 out of 100
- SIFT: 94 out of 100
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 80 out of 100
Same protein, different disease
- Paramyotonia congenita of Von Eulenburg is also caused by SCN4A variants; they fall partly in the same places as the Hyperkalemic periodic paralysis variants (15 disease-causing).
- Potassium-aggravated myotonia is also caused by SCN4A variants; they fall in the same places as the Hyperkalemic periodic paralysis variants (14 disease-causing).
- Hypokalemic periodic paralysis is also caused by SCN4A variants; they fall in the same places as the Hyperkalemic periodic paralysis variants (11 disease-causing).
- Congenital myopathy 22A, classic is also caused by SCN4A variants; they fall in the same places as the Hyperkalemic periodic paralysis variants (8 disease-causing).
- Congenital myasthenic syndrome 17 is also caused by SCN4A variants; they fall partly in the same places as the Hyperkalemic periodic paralysis variants (7 disease-causing).
- Congenital myotonia, autosomal dominant form is also caused by CLCN1 variants; they fall mostly in different places as the Hyperkalemic periodic paralysis variants (92 disease-causing).
- Congenital myotonia, autosomal recessive form is also caused by CLCN1 variants; they fall mostly in different places as the Hyperkalemic periodic paralysis variants (90 disease-causing).
- Skeletal muscle channelopathy is also caused by CLCN1 variants; they fall mostly in different places as the Hyperkalemic periodic paralysis variants (11 disease-causing).
Diseases related to Hyperkalemic periodic paralysis
- Hypokalemic periodic paralysis, also linked to CLCN1 and SCN4A
- Skeletal muscle channelopathy, also linked to CLCN1 and SCN4A
- Amyotrophic lateral sclerosis, also linked to SCN4A
- Congenital myotonia, autosomal dominant form, also linked to CLCN1
- Congenital myotonia, autosomal recessive form, also linked to CLCN1
- Cardiac arrhythmia, also linked to SCN4A
- Sotos syndrome, also linked to SCN4A
- Congenital myasthenic syndrome 17, also linked to SCN4A
- Epilepsy, also linked to SCN4A
- Paramyotonia congenita of Von Eulenburg, also linked to SCN4A
- Potassium-aggravated myotonia, also linked to SCN4A
- Congenital myopathy 22A, classic, also linked to SCN4A
Frequently asked questions
Which genes are linked to Hyperkalemic periodic paralysis?
In CATVariant, Hyperkalemic periodic paralysis is linked to 2 analyzed proteins: SCN4A (Sodium channel protein type 4 subunit alpha) and CLCN1 (Chloride channel protein 1).
How many genetic variants are linked to Hyperkalemic periodic paralysis?
843 variants: 63 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 765 are of uncertain significance or have conflicting reports.
Which uncertain variants in Hyperkalemic periodic paralysis look disease-causing?
9 uncertain variants reach the likely-pathogenic range of the ACMG/AMP points scale on computable evidence, for example SCN4A A715T, SCN4A S1434Y, SCN4A R1454Q, SCN4A R1463C and SCN4A F1705L. These are leads for expert review, not diagnoses.
Which variant effect predictor works best for Hyperkalemic periodic paralysis?
Among tools not trained on clinical labels, CADD separates this disease's known disease-causing variants from harmless ones best (AUROC 0.95, based on 28 disease-causing and 31 harmless variants).
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center